Pfizer Inc won U.S. and Canadian antitrust approval to buy smaller rival Wyeth on Wednesday, and will close the $66 billion deal this week, the world's largest drugmaker said.
Brazil's government will use regulation and its financial muscle to trump a wave of foreign takeovers in the nation's pharmaceutical industry, the daily newspaper Valor Economico said on Wednesday, citing a top official.
More than a dozen drugs including a cancer therapy and a bowel medicine are under early scrutiny for potential side effects, U.S. regulators said in a quarterly list released on Thursday.
Western drugmakers are stepping up the hunt for emerging market tigers in India.
A new compound can quickly counteract the action of an emerging class of drugs, offering a way to reverse the drugs' actions if a patient develops serious side effects, U.S. researchers said on Sunday.
U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.
U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.
U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.
Large drug companies have inherent advantages -- including cash to conduct expensive drug studies and to assure survival when trials fail -- that will be increasingly important in coming years, senior executives of Wyeth and Merck and Co said on Tuesday.
Gabapentin, a drug used to treat seizures, improves the quality of sleep in menopausal women bothered by hot flashes, University of Rochester Medical Center researchers report in the Journal of Women's Health.
Eli Lilly and Co said on Monday it plans to cut 5,500 jobs, or 13.5 percent of its workforce, as it girds for generic competition by 2011 on its Zyprexa schizophrenia drug and Gemzar cancer treatment.
Taking on corporate giants can feel like tilting at windmills, but John Kopchinski's six-year legal battle against Pfizer Inc just made him a rich man.
Pfizer Inc agreed on Wednesday to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.
What the Fed was Thinking; WatchDog Incompetency; Pfizer's Crime
Pfizer's Criminal Promotion; Modest Labor Gains; Millions for Bank Execs
Pfizer Inc agreed on Wednesday to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.
Pfizer Inc agreed on Wednesday to plead guilty to a criminal charge relating to promotions of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.
Pfizer Inc agreed on Wednesday to plead guilty to a criminal charge relating to promotions of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.
Pharmaceutical giant Pfizer Inc will pay a record $2.3 billion to settle civil and criminal charges about how it marketed some of its drugs under a settlement to be unveiled on Wednesday, a source said.
CHICAGO - An Abbott Laboratories Inc (ABT.N) unit that makes genetic tests will work with Pfizer Inc (PFE.N) to develop a test to screen non-small cell lung cancer (NSCLC) tumors to determine which patients are good candidates for a novel cancer therapy being developed by Pfizer.
Drug maker Pfizer's Venezuelan unit paid 36.59 million bolivars ($17 million) in back taxes after auditors questioned its transfer pricing methodology, Venezuela's tax service said in a statement on Tuesday.
Women who quickly put on pounds after starting birth-control injections seem to be at risk of significant long-term weight gain, a new study suggests.
